Patients & Volunteers Information for those interested or currently participating in a clinical trial
	Research Sponsors Why you should choose Aurora for your clinical trials
	Investigators & Coordinators Learn more about our services
	Research Matters Quarterly newsletter about research at Aurora
	Links Learn more about clinical research
	Contact us Contact the Clinical Research department
	Return home Return to the Clinical Research home page

Select from the search options to widen or narrow the search results.

A Study of High Dose Interferon for Metastatic Melanoma (ECOG E1697)

The purpose of this study is to evaluate if treatment with interferon is effective as adjuvant therapy in the intermediate risk group.

Participants must be:

• Over 18 years old, both male and female
• Only patients with initial presence of primary melanoma are eligible.
• No prior treatment for melanoma

For more information at VLCC Greenbay - Marinette please contact Kate Newbanks RN, BSN,ONC, phone: 920-288-4115 email kate.newbanks@auroa.org or Lori McElrone CCRC phone:920-288-4174 email lori.mcelrone@aurora.org

Principle Investigator: Dhimant Patel MD

For more information at VLCC-Elkhorn please contact Carol Thomas BS, MT, CCRC phone 414-649-5605 email carol.thomas@aurora.org

Principle Investigator:Rossana Madamba MD

For more information at Medical Consultants VLCC- Slinger please contact Pamela Rynes RN, BSN, CCRC phone 414-649-6067 email pam.rynes@aurora.org

Principle Investigator: Jonathan Treisman MD

Clinical trial location(s)

Aurora St. Luke's Medical Center
2900 West Oklahoma Avenue
Milwaukee, WI 53215

VLCC - Elkhorn
W3985 County Road NN
Elkhorn, WI 53121

VLCC - Slinger
1061 East Commerce (Hwy. 60)
Slinger, WI 53086

[ previous page ]

Copyright Aurora Health Care, a not-for-profit health care provider serving Wisconsin.
3000 W. Montana St., Milwaukee, WI 53215, (414) 647-3000
Disclaimer | Privacy notice | Contact us
.